Synendos Therapeutics to raise CHF 20M in Series A financing led by Kurma Partners and Sunstone Life Science Ventures Biotech Health services Manufacturing Investments 11 November 2020 Share:
Round value (USD): 21.91m Round investors: Bernina BioInvest Essential Investments High-Tech Gründerfonds Kurma Life Science Partners Lichtsteiner Foundation Schroder Adveq Sunstone Life Science Ventures Zürcher Kantonalbank Company: Synendos Therapeutics Industry: Biotech Health services Manufacturing
Rejuveron in a CHF22.5M equity round backed by Korify, Gaingels, Biotech Financial Services Health services Pharma Investments 21 December 2020